483
Paul Schulz, M.D.FDA 483 - Paul Schulz, M.D. - July 22, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Paul Schulz, M.D., a clinical investigator in Houston, TX, was inspected by the FDA and received a Form 483 with three observations. The inspection revealed significant deficiencies in obtaining informed consent, maintaining accurate case histories, and ensuring proper study monitoring. These issues indicate a lack of adherence to regulatory requirements for clinical investigations.
- Office
- Dallas District Office
- Person
Open in Dashboard
ID · f259e7be-1fb1-4d69-ac1a-ccac362162de